{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:28:44Z","timestamp":1775064524386,"version":"3.50.1"},"reference-count":123,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Dietary supplements are readily available over the counter in the United States and are used by the majority of older adults to address a variety of concerns and conditions. Many older adults report using dietary supplements for cognitive health\u2014either to address memory loss or dementia or in efforts to prevent cognitive decline. Our objective for this narrative review is to summarize the available efficacy and safety data for several supplements commonly reported in our clinic as being used for symptoms of dementia. Using a validated survey instrument, we conducted a survey of patients in our tertiary referral center memory clinic population to assess for the most commonly reported supplements for cognition. In our review, we compare the strength of published medical and scientific evidence to advertising or other lay press claims made about the nine most reported supplements with the aim of providing a representation of general trends in this industry. We found little or no scientific evidence available to support the use of any of these substances to ameliorate memory loss or other cognitive symptoms. Although most appear safe in the studies conducted to date, several authors have highlighted the lack of Food and Drug Administration oversight in the supplement industry, raising concerns over unknown or undeclared contaminants in these over-the-counter products. This review will better prepare clinicians to discuss these considerations with their patients who are considering the use of dietary supplements.<\/jats:p>","DOI":"10.3390\/jcm13247541","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T12:38:56Z","timestamp":1733920736000},"page":"7541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review of Supplements That Patients Commonly Report Using for Dementia"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-6299","authenticated-orcid":false,"given":"Alexander","family":"Frolov","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2369-6964","authenticated-orcid":false,"given":"Audrey","family":"Wadood","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-5191","authenticated-orcid":false,"given":"Brendan J.","family":"Kelley","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"ref_1","unstructured":"Grand View Research (2024, August 24). U.S. Nutritional Supplements Market Trends. Available online: https:\/\/www.grandviewresearch.com\/industry-analysis\/us-nutritional-supplements-market-report."},{"key":"ref_2","unstructured":"GreatGreenWall (2024, August 24). Great Green Wall Website. Available online: https:\/\/www.greatgreenwall.org\/."},{"key":"ref_3","unstructured":"Nahin, R.L., Barnes, P.M., and Stussman, B.J. (2016). Expenditures on Complementary Health Approaches: United States, 2012, National Health Statistics Reports."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3945\/jn.117.255984","article-title":"Dietary Supplement Use Was Very High among Older Adults in the United States in 2011\u20132014","volume":"147","author":"Gahche","year":"2017","journal-title":"J. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12603-022-1732-9","article-title":"Dietary Supplement Use in Middle-aged and Older Adults","volume":"26","author":"Tan","year":"2022","journal-title":"J. Nutr. Health Aging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/jgs.18305","article-title":"Dietary supplement and complementary and alternative medicine use among older adults in Australia and the United States","volume":"71","author":"Fravel","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_7","unstructured":"AARP_Research (2024, August 24). 2019 AARP Brain Health and Dietary Supplements Survey. Available online: https:\/\/www.aarp.org\/content\/dam\/aarp\/research\/surveys_statistics\/health\/2019\/brain-health-and-dietary-supplements-report.doi.10.26419-2Fres.00318.001.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mehegan, L.R.G. (2024, August 24). Brain Health and Dietary Supplements: Where\u2019s the Evidence? 2019 AARP Brain Health and Dietary Supplements Survey. Available online: https:\/\/www.aarp.org\/pri\/topics\/health\/prevention-wellness\/brain-health-and-dietary-supplements-survey\/.","DOI":"10.26419\/res.00318.001"},{"key":"ref_9","unstructured":"New York State Attorney General (2024, August 24). Attorney General James Wins Trial Against Quincy Bioscience for Deceptive and Fraudulent Advertising of \u201cMemory Improvement\u201d Supplement Prevagen, Available online: https:\/\/ag.ny.gov\/press-release\/2024\/attorney-general-james-wins-trial-against-quincy-bioscience-deceptive-and."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1445S","DOI":"10.1093\/jn\/nxy124","article-title":"A Survey Instrument to Assess Intake of Dietary Supplements, Related Products, and Caffeine in High-Use Populations","volume":"148","author":"Caldwell","year":"2018","journal-title":"J. Nutr."},{"key":"ref_11","first-page":"4","article-title":"Effects of a Supplement Containing Apoaequorin on Verbal Learning in Older Adults in the Community","volume":"30","author":"Moran","year":"2016","journal-title":"Adv. Mind Body Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Detert, J.A., Adams, E.L., Lescher, J.D., Lyons, J.A., and Moyer, J.R. (2013). Pretreatment with apoaequorin protects hippocampal CA1 neurons from oxygen-glucose deprivation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079002"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156720505774932287","article-title":"A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer\u2019s type","volume":"2","author":"Schneider","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1474-4422(12)70206-5","article-title":"Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer\u2019s disease (GuidAge): A randomised placebo-controlled trial","volume":"11","author":"Vellas","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/gps.4103","article-title":"Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: A randomized, placebo-controlled, double-blind, multi-center trial","volume":"29","author":"Gavrilova","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","article-title":"Ginkgo biloba for prevention of dementia: A randomized controlled trial","volume":"300","author":"DeKosky","year":"2008","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.2009.1913","article-title":"Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial","volume":"302","author":"Snitz","year":"2009","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0031-1291217","article-title":"Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761(R) in Alzheimer\u2019s disease and vascular dementia: Results from a randomised controlled trial","volume":"45","author":"Ihl","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/svn-2017-000104","article-title":"Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: A randomised controlled trial","volume":"2","author":"Li","year":"2017","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Birks, J., and Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD003120.pub3"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1210\/endo.137.12.8940403","article-title":"In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides","volume":"137","author":"Amri","year":"1996","journal-title":"Endocrinology"},{"key":"ref_22","first-page":"633","article-title":"Use of ginkgolide B and a ginkgolide-activated response element to control gene transcription: Example of the adrenocortical peripheral-type benzodiazepine receptor","volume":"48","author":"Amri","year":"2002","journal-title":"Cell. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(95)01440-3","article-title":"Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide","volume":"712","author":"Oyama","year":"1996","journal-title":"Brain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/JBCPP.1997.8.4.301","article-title":"Neuron degeneration induced by verapamil and attenuated by EGb761","volume":"8","author":"Zhu","year":"1997","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-8993(97)00239-4","article-title":"Phospholipid breakdown and choline release under hypoxic conditions: Inhibition by bilobalide, a constituent of Ginkgo biloba","volume":"755","author":"Klein","year":"1997","journal-title":"Brain Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1460-9568.2000.00069.x","article-title":"The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid","volume":"12","author":"Bastianetto","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"ref_27","first-page":"75","article-title":"Protective effects of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity","volume":"21","author":"Zhou","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_28","first-page":"415","article-title":"Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells","volume":"21","author":"Song","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jnutbio.2004.06.008","article-title":"Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels","volume":"15","author":"Yao","year":"2004","journal-title":"J. Nutr. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.freeradbiomed.2006.08.015","article-title":"Protection by EGb 761 against beta-amyloid-induced neurotoxicity: Involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation","volume":"41","author":"Longpre","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2018.04.009","article-title":"Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells","volume":"44","author":"Gargouri","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s007020170016","article-title":"Age-related increase of oxidative stress-induced apoptosis in mice prevention by Ginkgo biloba extract (EGb761)","volume":"108","author":"Schindowski","year":"2001","journal-title":"J. Neural Transm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1054\/plef.2000.0217","article-title":"Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: Correlation with the anti-oxidant properties of the extract","volume":"63","author":"Drieu","year":"2000","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1523\/JNEUROSCI.3448-06.2006","article-title":"Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans","volume":"26","author":"Wu","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ptr.2007","article-title":"Protective effects of Ginkgo biloba extract against mercury(II)-induced cardiovascular oxidative damage in rats","volume":"21","author":"Sener","year":"2007","journal-title":"Phytother. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Brown","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","article-title":"Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial","volume":"26","author":"Small","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cox, K.H.M., White, D.J., Pipingas, A., Poorun, K., and Scholey, A. (2020). Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study. Nutrients, 12.","DOI":"10.3390\/nu12061678"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/aje\/kwj267","article-title":"Curry consumption and cognitive function in the elderly","volume":"164","author":"Ng","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0974-8520.110524","article-title":"Effects of turmeric on Alzheimer\u2019s disease with behavioral and psychological symptoms of dementia","volume":"33","author":"Hishikawa","year":"2012","journal-title":"Ayu"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","article-title":"Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology","volume":"22","author":"Frautschy","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease","volume":"326","author":"Begum","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40120-023-00454-z","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Investigating the Efficacy of a Whole Coffee Cherry Extract and Phosphatidylserine Formulation on Cognitive Performance of Healthy Adults with Self-Perceived Memory Problems","volume":"12","author":"Doma","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_48","first-page":"Cd011906","article-title":"Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life","volume":"12","author":"Rutjes","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ajcn\/63.3.306","article-title":"Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study","volume":"63","author":"Riggs","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3945\/ajcn.2008.26404","article-title":"A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease","volume":"88","author":"Kang","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Malouf, R., and Grimley Evans, J. (2003). The effect of vitamin B6 on cognition. Cochrane Database Syst. Rev., Cd004393.","DOI":"10.1002\/14651858.CD004393"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Malouf, R., and Grimley Evans, J. (2008). Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev., CD004514.","DOI":"10.1002\/14651858.CD004514.pub2"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ajcn\/nqaa239","article-title":"High folic acid or folate combined with low vitamin B-12 status: Potential but inconsistent association with cognitive function in a nationally representative cross-sectional sample of US older adults participating in the NHANES","volume":"112","author":"Bailey","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ajcn\/84.2.361","article-title":"Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: A randomized, placebo-controlled trial","volume":"84","author":"Eussen","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Malouf, R., and Areosa Sastre, A. (2003). Vitamin B12 for Cognition. Cochrane Database Syst. Rev., CD004394.","DOI":"10.1002\/14651858.CD004394"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ajcnut.2023.12.011","article-title":"Effect of multivitamin-mineral supplementation versus placebo on cognitive function: Results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS","volume":"119","author":"Vyas","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mehegan, L.R.G. (2024, August 24). A Look at Brain Health and Dietary Supplements: 2021 AARP Omni Survey of Supplement Use Among Adults Age 50 and Older. Available online: https:\/\/www.aarp.org\/content\/dam\/aarp\/research\/surveys_statistics\/health\/2021\/brain-health-and-dietary-supplements-fact-sheet-omni.doi.10.26419-2Fres.00318.003.pdf.","DOI":"10.26419\/res.00318.003"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2017.01.069","article-title":"Computational comparison of a calcium-dependent jellyfish protein (apoaequorin) and calmodulin-cholesterol in short-term memory maintenance","volume":"642","author":"Morrill","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e01832","DOI":"10.1002\/brb3.1832","article-title":"Apoaequorin differentially modulates fear memory in adult and aged rats","volume":"10","author":"Ehlers","year":"2020","journal-title":"Brain Behav."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2013.02.047","article-title":"Safety assessment of Apoaequorin, a protein preparation: Subchronic toxicity study in rats","volume":"57","author":"Moran","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_61","unstructured":"Prevagen (2024, September 04). Prevagen Website. Available online: https:\/\/prevagen.com\/."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/NRL.0b013e318172cf4d","article-title":"Alternative medicine and Alzheimer disease","volume":"14","author":"Kelley","year":"2008","journal-title":"Neurologist"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/146642408210200512","article-title":"The outlook for green pharmacy","volume":"102","author":"Griggs","year":"1982","journal-title":"R. Soc. Health J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1046\/j.1471-4159.2000.0742268.x","article-title":"The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C","volume":"74","author":"Bastianetto","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00018-003-2324-4","article-title":"Can different genetic changes characterize histogenetic subtypes and biologic behavior in sporadic malignant melanoma of the skin?","volume":"60","author":"Poetsch","year":"2003","journal-title":"Cell Mol. Life Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0928-0987(94)00073-9","article-title":"Neuroprotective effects of Ginkgo biloba constituents","volume":"3","author":"Krieglstein","year":"1995","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/0024-3205(86)90663-6","article-title":"Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism","volume":"39","author":"Krieglstein","year":"1986","journal-title":"Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-014-0167-6","article-title":"Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1\/2 and p38 MAPK activation","volume":"11","author":"Jiang","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.2174\/1568026615666150610142647","article-title":"Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature","volume":"15","author":"Nabavi","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1871527314666150202151440","article-title":"Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders","volume":"14","author":"Montes","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1871527320666210208125524","article-title":"Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761(R)) in Patients with Amnestic Mild Cognitive Impairment","volume":"20","author":"Bajenaru","year":"2021","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_73","unstructured":"(2024, September 04). Nature\u2019s Bounty Website\u2014Ginkgo biloba. Available online: https:\/\/www.naturesbounty.com\/our-products\/specialty\/diet-supplements\/ginkgo-biloba-120-mg-100-capsules\/."},{"key":"ref_74","unstructured":"(2024, September 04). Life Extension Website\u2014Ginkgo Biloba. Available online: https:\/\/www.lifeextension.com\/vitamins-supplements\/item01658\/ginkgo-biloba-certified-extract."},{"key":"ref_75","unstructured":"(2024, September 04). Natrol Website\u2014Ginkgo Biloba. Available online: https:\/\/www.natrol.com\/products\/ginkgo-biloba-brain-health-capsules."},{"key":"ref_76","first-page":"276","article-title":"Nutritional prevention of cognitive decline and dementia","volume":"89","author":"Dominguez","year":"2018","journal-title":"Acta Biomed."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneur.57.6.824","article-title":"Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study","volume":"57","author":"Ganguli","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ijc.24967","article-title":"The dark side of curcumin","volume":"126","author":"Salvador","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_79","first-page":"55","article-title":"Turmeric-induced Liver Injury","volume":"14","author":"Alghzawi","year":"2024","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e2425822","DOI":"10.1001\/jamanetworkopen.2024.25822","article-title":"Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults","volume":"7","author":"Likhitsup","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_81","unstructured":"(2024, September 04). Luma Nutrition Website\u2014Turmeric Curcumin. Available online: https:\/\/lumanutrition.com\/products\/turmeric-curcumin\/."},{"key":"ref_82","unstructured":"Delvin, M. (2024, September 04). It\u2019s Time to Brain Better: RB Launches Neuriva\u2122, a Dietary Supplement and Holistic Approach to Support Brain Health. Available online: https:\/\/www.prnewswire.com\/news-releases\/its-time-to-brain-better-rb-launches-neuriva-a-dietary-supplement-and-holistic-approach-to-support-brain-health-300837523.html."},{"key":"ref_83","unstructured":"(2024, September 06). Schiff\u2014Neuriva Website. Available online: https:\/\/www.schiffvitamins.com\/pages\/neuriva-brain-health-supplement-research."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.nut.2014.10.014","article-title":"Phosphatidylserine and the human brain","volume":"31","author":"Glade","year":"2015","journal-title":"Nutrition"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Snow, A.D., Cummings, J.A., Tanzi, R.E., and Lake, T. (2021). In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction\/inhibition of beta-amyloid protein fibrils and tau protein tangles: Key primary targets for memory loss. Sci. Rep., 11.","DOI":"10.1038\/s41598-020-79275-1"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S0007114512005338","article-title":"Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects","volume":"110","author":"Nemzer","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_87","first-page":"5647","article-title":"The Effects of Phosphatidylserine and Omega-3 Fatty Acid-Containing Supplement on Late Life Depression","volume":"7","author":"Komori","year":"2015","journal-title":"Ment. Illn."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease","volume":"29","author":"Cunnane","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref_89","unstructured":"Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) (2024, September 04). Dietary Supplement Label Database (DSLD), Available online: https:\/\/ods.od.nih.gov\/Research\/Dietary_Supplement_Label_Database.aspx."},{"key":"ref_90","unstructured":"Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline (1998). The National Academies Collection: Reports funded by National Institutes of Health. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline, National Academy of Sciences. National Academies Press (US) Copyright\u00a9 1998."},{"key":"ref_91","unstructured":"Aronson, J.K. (2016). Meyler\u2019s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, Elsevier."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/07315724.2017.1342576","article-title":"Effect of Alpinia galanga on Mental Alertness and Sustained Attention with or Without Caffeine: A Randomized Placebo-Controlled Study","volume":"36","author":"Srivastava","year":"2017","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, T., Steibel, J.P., and Willette, A.A. (2024). Vitamin B6, B12, and Folate\u2019s Influence on Neural Networks in the UK Biobank Cohort. Nutrients, 16.","DOI":"10.3390\/nu16132050"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Homocysteine Lowering Trialists\u2019 Collaboration","volume":"316","author":"Collaboration","year":"1998","journal-title":"BMJ"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","article-title":"Homocysteine, B Vitamins, and Cognitive Impairment","volume":"36","author":"Smith","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ajcn\/80.3.641","article-title":"Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention","volume":"80","author":"Bleie","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","article-title":"Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia","volume":"80","author":"Quadri","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/nutrit\/nuab057","article-title":"B vitamins and prevention of cognitive decline and incident dementia: A systematic review and meta-analysis","volume":"80","author":"Wang","year":"2022","journal-title":"Nutr. Rev."},{"key":"ref_100","unstructured":"(2024, September 07). Vitamin B6 Fact Sheet for Health Professionals, Available online: https:\/\/ods.od.nih.gov\/factsheets\/VitaminB6-HealthProfessional\/."},{"key":"ref_101","unstructured":"Mackey, A., Davis, S., and Gregory, J. (2006). Vitamin B6. Modern Nutrition in Health and Disease, Lippincott Williams and Wilkins."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinte.167.1.21","article-title":"Vitamin B6, B12, and folic acid supplementation and cognitive function: A systematic review of randomized trials","volume":"167","author":"Balk","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_103","first-page":"CD011905","article-title":"Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment","volume":"11","author":"McCleery","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.1990.tb28064.x","article-title":"Vitamin B6 safety issues","volume":"585","author":"Bendich","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/biof.174","article-title":"Unraveling the complex relationship between folate and cancer risk","volume":"37","author":"Mason","year":"2011","journal-title":"Biofactors"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: Diagnosis of dementia (an evidence-based review)","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alz.12077","article-title":"Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2","volume":"16","author":"Keenan","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1002\/alz.13033","article-title":"Dietary nutrient intake and cognitive function in the Age-Related Eye Disease Studies 1 and 2","volume":"19","author":"Keenan","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1002\/alz.13078","article-title":"Impact of multivitamin-mineral and cocoa extract on incidence of mild cognitive impairment and dementia: Results from the COcoa Supplement and Multivitamin Outcomes Study for the Mind (COSMOS-Mind)","volume":"19","author":"Sachs","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e2418729","DOI":"10.1001\/jamanetworkopen.2024.18729","article-title":"Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts","volume":"7","author":"Loftfield","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/dta.3529","article-title":"Unauthorized ingredients in \u201cnootropic\u201d dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents","volume":"15","author":"Jedrejko","year":"2023","journal-title":"Drug Test. Anal."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-pharmtox-010617-052844","article-title":"Adverse Effects of Nutraceuticals and Dietary Supplements","volume":"58","author":"Ronis","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jms.1452","article-title":"Nutritional supplements cross-contaminated and faked with doping substances","volume":"43","author":"Geyer","year":"2008","journal-title":"J. Mass Spectrom."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.2019.4967","article-title":"Dietary Supplements for Brain Health-Reply","volume":"321","author":"Hellmuth","year":"2019","journal-title":"JAMA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.2018.21560","article-title":"The Rise of Pseudomedicine for Dementia and Brain Health","volume":"321","author":"Hellmuth","year":"2019","journal-title":"JAMA"},{"key":"ref_117","unstructured":"Stanford (2024, September 05). Stanford Center on Longevity Expert Consensus Statement on Brain Health. Available online: https:\/\/longevity.stanford.edu\/expert-consensus-on-brain-health\/."},{"key":"ref_118","unstructured":"Alzheimer_Association (2024, September 05). Alzheimer\u2019s Association Website Regarding Alternative Treatments. Available online: https:\/\/www.alz.org\/alzheimers-dementia\/treatments\/alternative-treatments."},{"key":"ref_119","unstructured":"ResearchAndMarkets.com (2024, September 04). Global Brain Health Supplements Market Report. Available online: https:\/\/finance.yahoo.com\/news\/global-brain-health-supplements-market-111800756.html."},{"key":"ref_120","unstructured":"Federal Trade Commission (2024, August 24). FTC Health Products Compliance Guidance, Available online: https:\/\/www.ftc.gov\/system\/files\/ftc_gov\/pdf\/Health-Products-Compliance-Guidance.pdf."},{"key":"ref_121","unstructured":"(2024, September 07). In the Matter of POM Wonderful LLC and Roll Global LLC, as Successor in Interest to Roll International Corporation, Companies, and Stewart A. Resnick, Lynda Rae Resnick, and Matthew Tupper, Individually and as Officers of the Companies, Available online: https:\/\/www.ftc.gov\/system\/files\/documents\/cases\/160614pomorder.pdf."},{"key":"ref_122","unstructured":"(2024, September 07). Federal Trade Commission Complaint, Available online: https:\/\/www.ftc.gov\/system\/files\/documents\/cases\/2014-03_pomwonderful_dccir_ftcoppbrieffinal.pdf."},{"key":"ref_123","unstructured":"POM Wonderful LLC, et al (2024, September 07). Case Timeline, Available online: https:\/\/www.ftc.gov\/legal-library\/browse\/cases-proceedings\/pom-wonderful-llc-et-al."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:52:22Z","timestamp":1760115142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":123,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247541"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247541","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}